Hypercoagulability in hereditary hemorrhagic telangiectasia with epilepsy

Journal of Neurosciences in Rural Practice

Ernst Sehnal¹  Josef Finsterer² 

[1]Department of Cardiology and Intensive Care Medicine, General Hospital Rudolfstiftung, Vienna, Austria, Europe

[2]Department of Neurological, General Hospital Rudolfstiftung, Vienna, Austria, Europe

关键词: antithrombotic agents;    blood coagulation factors;    risk factors;    thrombophilia;    thrombosis;   

DOI  :  10.4103/0976-3147.158791

来源: DOAJ

【 摘 要 】

Recent data indicate that in patients with hereditary hemorrhagic teleangiectasia (HHT), low iron levels due to inadequate replacement after hemorrhagic iron losses are associated with elevated factor-VIII plasma levels and consecutively increased risk of venous thrombo-embolism. Here, we report a patient with HHT, low iron levels, elevated factor-VIII, and recurrent venous thrombo-embolism. A 64-year-old multimorbid Serbian gipsy was diagnosed with HHT at age 62 years. He had a history of recurrent epistaxis, teleangiectasias on the lips, renal and pulmonary arterio-venous malformations, and a family history positive for HHT. He had experienced recurrent venous thrombosis (mesenteric vein thrombosis, portal venous thrombosis, deep venous thrombosis), insufficiently treated with phenprocoumon during 16 months and gastro-intestinal bleeding. Blood tests revealed sideropenia and elevated plasma levels of coagulation factor-VIII. His history was positive for diabetes, arterial hypertension, hyperlipidemia, smoking, cerebral abscess, recurrent ischemic stroke, recurrent ileus, peripheral arterial occluding disease, polyneuropathy, mild renal insufficiency, and epilepsy. Following recent findings, hypercoagulability was attributed to the sideropenia-induced elevation of coagulation factor-VIII. In conclusion, HHT may be associated with hypercoagulability due to elevated factor-VIII associated with low serum iron levels from recurrent bleeding. Iron substitution may prevent HHT patients from hypercoagulability.

【 授权许可】

Unknown